1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti-influenza Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Oseltamivir 1.2.3 Zanamivir 1.2.4 Peramivir 1.2.5 Other 1.3 Market by Application 1.3.1 Global Anti-influenza Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Children 1.3.3 Adults 1.3.4 Elderly 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti-influenza Drugs Market Perspective (2016-2027) 2.2 Anti-influenza Drugs Growth Trends by Regions 2.2.1 Anti-influenza Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Anti-influenza Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Anti-influenza Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Anti-influenza Drugs Industry Dynamic 2.3.1 Anti-influenza Drugs Market Trends 2.3.2 Anti-influenza Drugs Market Drivers 2.3.3 Anti-influenza Drugs Market Challenges 2.3.4 Anti-influenza Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-influenza Drugs Players by Revenue 3.1.1 Global Top Anti-influenza Drugs Players by Revenue (2016-2021) 3.1.2 Global Anti-influenza Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Anti-influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anti-influenza Drugs Revenue 3.4 Global Anti-influenza Drugs Market Concentration Ratio 3.4.1 Global Anti-influenza Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti-influenza Drugs Revenue in 2020 3.5 Anti-influenza Drugs Key Players Head office and Area Served 3.6 Key Players Anti-influenza Drugs Product Solution and Service 3.7 Date of Enter into Anti-influenza Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-influenza Drugs Breakdown Data by Type 4.1 Global Anti-influenza Drugs Historic Market Size by Type (2016-2021) 4.2 Global Anti-influenza Drugs Forecasted Market Size by Type (2022-2027) 5 Anti-influenza Drugs Breakdown Data by Application 5.1 Global Anti-influenza Drugs Historic Market Size by Application (2016-2021) 5.2 Global Anti-influenza Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anti-influenza Drugs Market Size (2016-2027) 6.2 North America Anti-influenza Drugs Market Size by Type 6.2.1 North America Anti-influenza Drugs Market Size by Type (2016-2021) 6.2.2 North America Anti-influenza Drugs Market Size by Type (2022-2027) 6.2.3 North America Anti-influenza Drugs Market Size by Type (2016-2027) 6.3 North America Anti-influenza Drugs Market Size by Application 6.3.1 North America Anti-influenza Drugs Market Size by Application (2016-2021) 6.3.2 North America Anti-influenza Drugs Market Size by Application (2022-2027) 6.3.3 North America Anti-influenza Drugs Market Size by Application (2016-2027) 6.4 North America Anti-influenza Drugs Market Size by Country 6.4.1 North America Anti-influenza Drugs Market Size by Country (2016-2021) 6.4.2 North America Anti-influenza Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anti-influenza Drugs Market Size (2016-2027) 7.2 Europe Anti-influenza Drugs Market Size by Type 7.2.1 Europe Anti-influenza Drugs Market Size by Type (2016-2021) 7.2.2 Europe Anti-influenza Drugs Market Size by Type (2022-2027) 7.2.3 Europe Anti-influenza Drugs Market Size by Type (2016-2027) 7.3 Europe Anti-influenza Drugs Market Size by Application 7.3.1 Europe Anti-influenza Drugs Market Size by Application (2016-2021) 7.3.2 Europe Anti-influenza Drugs Market Size by Application (2022-2027) 7.3.3 Europe Anti-influenza Drugs Market Size by Application (2016-2027) 7.4 Europe Anti-influenza Drugs Market Size by Country 7.4.1 Europe Anti-influenza Drugs Market Size by Country (2016-2021) 7.4.2 Europe Anti-influenza Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anti-influenza Drugs Market Size (2016-2027) 8.2 Asia-Pacific Anti-influenza Drugs Market Size by Type 8.2.1 Asia-Pacific Anti-influenza Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Anti-influenza Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Anti-influenza Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Anti-influenza Drugs Market Size by Application 8.3.1 Asia-Pacific Anti-influenza Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Anti-influenza Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Anti-influenza Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Anti-influenza Drugs Market Size by Region 8.4.1 Asia-Pacific Anti-influenza Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Anti-influenza Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anti-influenza Drugs Market Size (2016-2027) 9.2 Latin America Anti-influenza Drugs Market Size by Type 9.2.1 Latin America Anti-influenza Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Anti-influenza Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Anti-influenza Drugs Market Size by Type (2016-2027) 9.3 Latin America Anti-influenza Drugs Market Size by Application 9.3.1 Latin America Anti-influenza Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Anti-influenza Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Anti-influenza Drugs Market Size by Application (2016-2027) 9.4 Latin America Anti-influenza Drugs Market Size by Country 9.4.1 Latin America Anti-influenza Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Anti-influenza Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-influenza Drugs Market Size (2016-2027) 10.2 Middle East & Africa Anti-influenza Drugs Market Size by Type 10.2.1 Middle East & Africa Anti-influenza Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Anti-influenza Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Anti-influenza Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Anti-influenza Drugs Market Size by Application 10.3.1 Middle East & Africa Anti-influenza Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Anti-influenza Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Anti-influenza Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Anti-influenza Drugs Market Size by Country 10.4.1 Middle East & Africa Anti-influenza Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Anti-influenza Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Anti-influenza Drugs Introduction 11.1.4 Roche Revenue in Anti-influenza Drugs Business (2016-2021) 11.1.5 Roche Recent Development 11.2 HEC Pharm 11.2.1 HEC Pharm Company Details 11.2.2 HEC Pharm Business Overview 11.2.3 HEC Pharm Anti-influenza Drugs Introduction 11.2.4 HEC Pharm Revenue in Anti-influenza Drugs Business (2016-2021) 11.2.5 HEC Pharm Recent Development 11.3 Shanghai Zhongxisanwei 11.3.1 Shanghai Zhongxisanwei Company Details 11.3.2 Shanghai Zhongxisanwei Business Overview 11.3.3 Shanghai Zhongxisanwei Anti-influenza Drugs Introduction 11.3.4 Shanghai Zhongxisanwei Revenue in Anti-influenza Drugs Business (2016-2021) 11.3.5 Shanghai Zhongxisanwei Recent Development 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Details 11.4.2 GlaxoSmithKline Business Overview 11.4.3 GlaxoSmithKline Anti-influenza Drugs Introduction 11.4.4 GlaxoSmithKline Revenue in Anti-influenza Drugs Business (2016-2021) 11.4.5 GlaxoSmithKline Recent Development 11.5 Guangzhou Pharmaceutical 11.5.1 Guangzhou Pharmaceutical Company Details 11.5.2 Guangzhou Pharmaceutical Business Overview 11.5.3 Guangzhou Pharmaceutical Anti-influenza Drugs Introduction 11.5.4 Guangzhou Pharmaceutical Revenue in Anti-influenza Drugs Business (2016-2021) 11.5.5 Guangzhou Pharmaceutical Recent Development 11.6 Hunan Nucien Pharmaceutical 11.6.1 Hunan Nucien Pharmaceutical Company Details 11.6.2 Hunan Nucien Pharmaceutical Business Overview 11.6.3 Hunan Nucien Pharmaceutical Anti-influenza Drugs Introduction 11.6.4 Hunan Nucien Pharmaceutical Revenue in Anti-influenza Drugs Business (2016-2021) 11.6.5 Hunan Nucien Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Anti-influenza Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Oseltamivir Table 3. Key Players of Zanamivir Table 4. Key Players of Peramivir Table 5. Key Players of Other Table 6. Global Anti-influenza Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Anti-influenza Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Anti-influenza Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Anti-influenza Drugs Market Share by Regions (2016-2021) Table 10. Global Anti-influenza Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Anti-influenza Drugs Market Share by Regions (2022-2027) Table 12. Anti-influenza Drugs Market Trends Table 13. Anti-influenza Drugs Market Drivers Table 14. Anti-influenza Drugs Market Challenges Table 15. Anti-influenza Drugs Market Restraints Table 16. Global Anti-influenza Drugs Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Anti-influenza Drugs Market Share by Players (2016-2021) Table 18. Global Top Anti-influenza Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-influenza Drugs as of 2020) Table 19. Ranking of Global Top Anti-influenza Drugs Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Anti-influenza Drugs Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Anti-influenza Drugs Product Solution and Service Table 23. Date of Enter into Anti-influenza Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Anti-influenza Drugs Market Size by Type (2016-2021) (US$ Million) Table 26. Global Anti-influenza Drugs Revenue Market Share by Type (2016-2021) Table 27. Global Anti-influenza Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Anti-influenza Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Anti-influenza Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Anti-influenza Drugs Revenue Market Share by Application (2016-2021) Table 31. Global Anti-influenza Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Anti-influenza Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Anti-influenza Drugs Market Size by Type (2016-2021) (US$ Million) Table 34. North America Anti-influenza Drugs Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Anti-influenza Drugs Market Size by Application (2016-2021) (US$ Million) Table 36. North America Anti-influenza Drugs Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Anti-influenza Drugs Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Anti-influenza Drugs Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Anti-influenza Drugs Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Anti-influenza Drugs Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Anti-influenza Drugs Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Anti-influenza Drugs Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Anti-influenza Drugs Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Anti-influenza Drugs Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Anti-influenza Drugs Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Anti-influenza Drugs Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Anti-influenza Drugs Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Anti-influenza Drugs Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Anti-influenza Drugs Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Anti-influenza Drugs Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Anti-influenza Drugs Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Anti-influenza Drugs Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Anti-influenza Drugs Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Anti-influenza Drugs Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Anti-influenza Drugs Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Anti-influenza Drugs Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Anti-influenza Drugs Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Anti-influenza Drugs Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Anti-influenza Drugs Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Anti-influenza Drugs Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Anti-influenza Drugs Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Anti-influenza Drugs Market Size by Country (2022-2027) & (US$ Million) Table 63. Roche Company Details Table 64. Roche Business Overview Table 65. Roche Anti-influenza Drugs Product Table 66. Roche Revenue in Anti-influenza Drugs Business (2016-2021) & (US$ Million) Table 67. Roche Recent Development Table 68. HEC Pharm Company Details Table 69. HEC Pharm Business Overview Table 70. HEC Pharm Anti-influenza Drugs Product Table 71. HEC Pharm Revenue in Anti-influenza Drugs Business (2016-2021) & (US$ Million) Table 72. HEC Pharm Recent Development Table 73. Shanghai Zhongxisanwei Company Details Table 74. Shanghai Zhongxisanwei Business Overview Table 75. Shanghai Zhongxisanwei Anti-influenza Drugs Product Table 76. Shanghai Zhongxisanwei Revenue in Anti-influenza Drugs Business (2016-2021) & (US$ Million) Table 77. Shanghai Zhongxisanwei Recent Development Table 78. GlaxoSmithKline Company Details Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Anti-influenza Drugs Product Table 81. GlaxoSmithKline Revenue in Anti-influenza Drugs Business (2016-2021) & (US$ Million) Table 82. GlaxoSmithKline Recent Development Table 83. Guangzhou Pharmaceutical Company Details Table 84. Guangzhou Pharmaceutical Business Overview Table 85. Guangzhou Pharmaceutical Anti-influenza Drugs Product Table 86. Guangzhou Pharmaceutical Revenue in Anti-influenza Drugs Business (2016-2021) & (US$ Million) Table 87. Guangzhou Pharmaceutical Recent Development Table 88. Hunan Nucien Pharmaceutical Company Details Table 89. Hunan Nucien Pharmaceutical Business Overview Table 90. Hunan Nucien Pharmaceutical Anti-influenza Drugs Product Table 91. Hunan Nucien Pharmaceutical Revenue in Anti-influenza Drugs Business (2016-2021) & (US$ Million) Table 92. Hunan Nucien Pharmaceutical Recent Development Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-influenza Drugs Market Share by Type: 2020 VS 2027 Figure 2. Oseltamivir Features Figure 3. Zanamivir Features Figure 4. Peramivir Features Figure 5. Other Features Figure 6. Global Anti-influenza Drugs Market Share by Application: 2020 VS 2027 Figure 7. Children Case Studies Figure 8. Adults Case Studies Figure 9. Elderly Case Studies Figure 10. Anti-influenza Drugs Report Years Considered Figure 11. Global Anti-influenza Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Anti-influenza Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Anti-influenza Drugs Market Share by Regions: 2020 VS 2027 Figure 14. Global Anti-influenza Drugs Market Share by Regions (2022-2027) Figure 15. Global Anti-influenza Drugs Market Share by Players in 2020 Figure 16. Global Top Anti-influenza Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-influenza Drugs as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Anti-influenza Drugs Revenue in 2020 Figure 18. Global Anti-influenza Drugs Revenue Market Share by Type (2016-2021) Figure 19. Global Anti-influenza Drugs Revenue Market Share by Type (2022-2027) Figure 20. North America Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Anti-influenza Drugs Market Share by Type (2016-2027) Figure 22. North America Anti-influenza Drugs Market Share by Application (2016-2027) Figure 23. North America Anti-influenza Drugs Market Share by Country (2016-2027) Figure 24. United States Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Anti-influenza Drugs Market Share by Type (2016-2027) Figure 28. Europe Anti-influenza Drugs Market Share by Application (2016-2027) Figure 29. Europe Anti-influenza Drugs Market Share by Country (2016-2027) Figure 30. Germany Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Anti-influenza Drugs Market Share by Type (2016-2027) Figure 38. Asia-Pacific Anti-influenza Drugs Market Share by Application (2016-2027) Figure 39. Asia-Pacific Anti-influenza Drugs Market Share by Region (2016-2027) Figure 40. China Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Anti-influenza Drugs Market Share by Type (2016-2027) Figure 48. Latin America Anti-influenza Drugs Market Share by Application (2016-2027) Figure 49. Latin America Anti-influenza Drugs Market Share by Country (2016-2027) Figure 50. Mexico Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Anti-influenza Drugs Market Share by Type (2016-2027) Figure 54. Middle East & Africa Anti-influenza Drugs Market Share by Application (2016-2027) Figure 55. Middle East & Africa Anti-influenza Drugs Market Share by Country (2016-2027) Figure 56. Turkey Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Anti-influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Roche Revenue Growth Rate in Anti-influenza Drugs Business (2016-2021) Figure 60. HEC Pharm Revenue Growth Rate in Anti-influenza Drugs Business (2016-2021) Figure 61. Shanghai Zhongxisanwei Revenue Growth Rate in Anti-influenza Drugs Business (2016-2021) Figure 62. GlaxoSmithKline Revenue Growth Rate in Anti-influenza Drugs Business (2016-2021) Figure 63. Guangzhou Pharmaceutical Revenue Growth Rate in Anti-influenza Drugs Business (2016-2021) Figure 64. Hunan Nucien Pharmaceutical Revenue Growth Rate in Anti-influenza Drugs Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Roche HEC Pharm Shanghai Zhongxisanwei GlaxoSmithKline Guangzhou Pharmaceutical Hunan Nucien Pharmaceutical